LONDON MARKET MIDDAY: Underwhelming Oil Output Cut Knocks BP And Shell Read More
UK TOP NEWS SUMMARY: AstraZeneca Initiates Trial For Calquence Drug Read More
UK WINNERS & LOSERS SUMMARY: AstraZeneca Up On Tagrisso Trial Success Read More
TOP NEWS: Astra, Merck Get US Approval For Neurofibromatosis Treatment Read More
LONDON MARKET OPEN: Stocks Mixed; AstraZeneca Rises On Trial Success Read More
Covid-19 Antibody Test Could Be Scaled Up By May End Says AstraZeneca Read More
UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders Read More
Circassia Wants To Terminate AstraZeneca Deal And Transfer Drug Rights Read More
UK BROKER RATINGS SUMMARY: RBC Cuts Anglo And Anto; Goldman Ups BHP Read More
AstraZeneca Completes Divestment Of Movantik Drug To RedHill Read More
AstraZeneca's Farxiga Trial Ends Early Due To "Overwhelming Efficacy" Read More
AstraZeneca's Hyperkalaemia Drug Lokelma Gets Approval In Japan Read More
UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend Read More
Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca Read More
UK Dividends Calendar - Next 7 Days Read More
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares Read More
Japan Gives AstraZeneca's Lynparza Orphan Status In Pancreatic Cancer Read More
UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa Read More
AstraZeneca's Caspian Trial Confirms Survival Benefit Of Imfinzi Read More
AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint Read More